NPLY · XBRL financial data

Naploy financial statements, every quarter

The same tables from 11 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (NPLY's year ends in late July)

In thousands of dollars	Q2 FY24Jan 31, 2024	Q3 FY24Apr 30, 2024	Q4 FY24Jul 31, 2024	Q1 FY25Oct 31, 2024	Q2 FY25Jan 31, 2025	Q3 FY25Apr 30, 2025	Q4 FY25Jul 31, 2025	Q1 FY26Oct 31, 2025	Q2 FY26Jan 31, 2026	Q3 FY26Apr 30, 2026	Q4 FY26Jul 31, 2026
Revenue	0	0	0*	1	2	2	4*	4	5	5	5*
General and administrative	0	0	0*	0	0	0	0*	0	0	0	21*
Total operating expenses	6	6	5*	11	6	5	7*	11	6	5	28*
Operating income (loss)	(6)	(6)	(5)*	(10)	(3)	(4)	(3)*	(7)	(1)	(0)	(23)*
Income tax expense (benefit)	0	0	0*	0	0	0	0*	0	0	0	0*
Net income (loss)	(6)	(6)	(5)*	(10)	(3)	(4)	(3)*	(7)	(1)	(0)	(23)*
Earnings per share, basic USD per share	0.00	0.00	—	0.00	0.00	0.00	0.00*	0.00	0.00	0.00	(0.01)*
Earnings per share, diluted USD per share	0.00	0.00	—	0.00	0.00	0.00	0.00*	0.00	0.00	0.00	(0.01)*
Weighted average shares, basic thousands of shares	2,000	2,134	—	3,783	3,803	3,803	3,804*	3,803	3,803	3,803	3,803*
Weighted average shares, diluted thousands of shares	2,000	2,134	—	3,783	3,803	3,803	3,804*	3,803	3,803	3,803	3,803*

Fiscal quarters (NPLY's year ends in late July)

In thousands of dollars	Q2 FY24Jan 31, 2024	Q3 FY24Apr 30, 2024	Q4 FY24Jul 31, 2024	Q1 FY25Oct 31, 2024	Q2 FY25Jan 31, 2025	Q3 FY25Apr 30, 2025	Q4 FY25Jul 31, 2025	Q1 FY26Oct 31, 2025	Q2 FY26Jan 31, 2026	Q3 FY26Apr 30, 2026	Q4 FY26Jul 31, 2026
Cash and cash equivalents	1	8	32	28	27	10	13	10	7	16	20
Total current assets	1	8	32	28	27	30	33	30	27	36	40
Total assets	41	46	68	61	59	59	59	54	49	56	58
Accounts payable	0	—	0	—	—	—	0	—	—	0	—
Total current liabilities	56	60	60	62	63	67	70	73	68	76	101
Accumulated deficit	(15)	(22)	(27)	(37)	(40)	(44)	(47)	(55)	(56)	(56)	(79)
Total stockholders' equity	(15)	(14)	8	(0)	(4)	(8)	(11)	(18)	(19)	(20)	(43)
Total liabilities and equity	41	46	68	61	59	59	59	54	49	56	58
Common shares outstanding (cover page) thousands of shares	2,000	2,608	3,803	3,803	3,803	3,803	3,803	3,803	3,803	3,803	3,803

Fiscal quarters (NPLY's year ends in late July)

In thousands of dollars	Q2 FY24Jan 31, 2024	Q3 FY24Apr 30, 2024	Q4 FY24Jul 31, 2024	Q1 FY25Oct 31, 2024	Q2 FY25Jan 31, 2025	Q3 FY25Apr 30, 2025	Q4 FY25Jul 31, 2025	Q1 FY26Oct 31, 2025	Q2 FY26Jan 31, 2026	Q3 FY26Apr 30, 2026	Q4 FY26Jul 31, 2026
Net income (loss)	(6)	(6)	(5)*	(10)	(3)	(4)	(3)*	(7)	(1)	(0)	(23)*
Net cash from operating activities	(4)*	(4)*	(3)*	(6)	(0)*	(17)*	2*	(3)	(3)*	9*	(16)*
Net cash from investing activities	0*	0*	0*	0	0*	0*	0*	—	—	—	—
Proceeds from issuing common stock	0*	8*	27*	1	0*	0*	0*	0	0*	0*	0*
Net cash from financing activities	0*	11*	27*	1	0*	0*	0*	0	0*	0*	21*

SIC 8000 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8000 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.
A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Naploy	20	5*	(16)*	3.8M	1.2 quarters	Q4 FY26 10-KJul 31, 2026
Alps Group	not reported	not reported	not reported	not reported	—	—
American Oncology Network	62,849	490,884*	11,926*	not reported	—	Q4 FY24 10-KDec 31, 2024
Agape ATP	45	109	(110)*	1.0M	0.4 quarters	Q2 FY26 10-QJun 30, 2026
Anew Health	not reported	not reported	not reported	not reported	—	—
Better Therapeutics	6,598	not reported	(5,943)*	47.4M	1.1 quarters	Q3 FY23 10-QSep 30, 2023
DocGo	25,233	73,425	(9,242)*	98.9M	2.7 quarters	Q2 FY26 10-QJun 30, 2026
EUDA Health Holdings	345	year only	year only	1.9M	—	Q4 FY25 20-FDec 31, 2025
InnovAge Holding	97,891	261,951*	21,289*	136.5M	—	Q4 FY26 10-KJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.